Yuta Taniguchi Selected Research

Yuta Taniguchi Research Topics

Disease

30	Neoplasms (Cancer) 05/2024 - 11/2016
11	Osteosarcoma (Osteogenic Sarcoma) 06/2023 - 11/2016
6	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 02/2017
6	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2022
5	Infections 05/2023 - 01/2017
4	COVID-19 04/2024 - 12/2021
4	Spontaneous Fractures (Pathological Fracture) 05/2023 - 01/2017
3	Hemorrhage 01/2022 - 01/2018
2	Fibrosarcoma 06/2023 - 02/2020
2	Margins of Excision 05/2023 - 10/2018
2	Giant Cell Tumor of Bone 01/2023 - 07/2020
2	Death (Near-Death Experience) 11/2021 - 08/2021
2	Synovial Sarcoma (Synovioma) 07/2021 - 02/2020
2	Hyperthermia 01/2018 - 01/2018
1	Rhabdomyosarcoma 05/2024
1	Carcinoma (Carcinomatosis) 05/2024
1	Pain (Aches) 05/2024
1	Oncogenic osteomalacia 04/2024
1	Kimura Disease 05/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Wounds and Injuries (Trauma) 09/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Heart Neoplasms 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Necrosis 01/2021
1	Shock 07/2020
1	Osteoarthritis 07/2020
1	Bone Cysts (Bone Cyst) 05/2018
1	Disease Progression 01/2018
1	Chondrosarcoma 01/2018

Drug/Important Bio-Agent (IBA)

8	NitrogenIBA 04/2024 - 10/2017
3	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2022
3	calcium phosphateIBA 01/2023 - 01/2018
2	Ifosfamide FDA LinkGeneric 05/2024 - 01/2021
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023 - 01/2018
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	IodineIBA 01/2023 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2021
2	Bone SubstitutesIBA 05/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024
1	Dactinomycin (Actinomycin)FDA LinkGeneric 05/2024
1	Vincristine (Oncovin)FDA LinkGeneric 05/2024
1	C-Reactive ProteinIBA 05/2024
1	Fibroblast Growth Factor-23IBA 04/2024
1	Mucin-1 (CA 15-3 Antigen)IBA 06/2023
1	VimentinIBA 06/2023
1	MicroRNAs (MicroRNA)IBA 06/2023
1	Hemostatics (Antihemorrhagics)IBA 05/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Denosumab FDA Link 01/2023
1	Indicators and Reagents (Reagents)IBA 02/2022
1	AnticoagulantsIBA 01/2022
1	NivolumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	Vitamin K FDA Link 01/2022
1	nafamostatIBA 12/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Polymethyl Methacrylate (Sol)IBA 07/2020
1	Phosphates (Orthophosphate)IBA 05/2020
1	PlatinumIBA 05/2020
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 05/2020
1	Platinum Compounds (Compounds, Platinum)IBA 05/2020
1	Glycogen Synthase KinasesIBA 02/2020
1	Cyclin D1IBA 02/2020
1	CollagenIBA 02/2020
1	TitaniumIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	pyranoprofen (pranoprofen)IBA 01/2018
1	PPAR gammaIBA 01/2018

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 05/2024 - 11/2016
5	Neoadjuvant Therapy 04/2021 - 10/2017
4	Radiotherapy 05/2024 - 01/2018
4	Long-Term Care 04/2024 - 08/2021
4	Therapeutics 01/2022 - 06/2017
3	Limb Salvage 04/2024 - 02/2020
3	Osteotomy 07/2020 - 10/2017
3	Operative Time 01/2019 - 01/2017
2	Tourniquets 05/2023 - 01/2018
2	Curettage 11/2022 - 07/2020
2	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Prostheses and Implants (Prosthesis) 01/2021 - 02/2020
1	Operative Surgical Procedures 05/2024
1	Surgical Amputation (Amputations) 05/2023
1	Hemostatic Techniques 05/2023
1	Orthopedic Procedures 05/2023
1	Conservative Treatment 09/2022
1	Artificial Respiration (Mechanical Ventilation) 03/2022
1	Nephrectomy 01/2022
1	Immunotherapy 01/2022
1	Adjuvant Chemotherapy 01/2021
1	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2020
1	Replacement Arthroplasty 04/2019
1	Transjugular Intrahepatic Portasystemic Shunt 01/2019
1	Diskectomy (Discectomy) 01/2019
1	Salvage Therapy 01/2018